- Home
- SRL vs ADAG Comparison
SRL vs ADAG Comparison
Compare SRL & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- ADAG
- Stock Information
- Founded
- SRL 2017
- ADAG 2011
- Country
- SRL China
- ADAG China
- Employees
- SRL N/A
- ADAG N/A
- Industry
- SRL Professional Services
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- SRL Consumer Discretionary
- ADAG Health Care
- Exchange
- SRL Nasdaq
- ADAG Nasdaq
- Market Cap
- SRL 109.8M
- ADAG 91.2M
- IPO Year
- SRL N/A
- ADAG 2021
- Fundamental
- Price
- SRL $6.75
- ADAG $2.10
- Analyst Decision
- SRL
- ADAG Strong Buy
- Analyst Count
- SRL 0
- ADAG 1
- Target Price
- SRL N/A
- ADAG $5.00
- AVG Volume (30 Days)
- SRL 9.3K
- ADAG 89.6K
- Earning Date
- SRL 12-27-2024
- ADAG 07-25-2024
- Dividend Yield
- SRL N/A
- ADAG N/A
- EPS Growth
- SRL N/A
- ADAG N/A
- EPS
- SRL 0.07
- ADAG N/A
- Revenue
- SRL $41,604,386.00
- ADAG $815,746.00
- Revenue This Year
- SRL N/A
- ADAG N/A
- Revenue Next Year
- SRL N/A
- ADAG $2.70
- P/E Ratio
- SRL $99.34
- ADAG N/A
- Revenue Growth
- SRL N/A
- ADAG N/A
- 52 Week Low
- SRL $5.74
- ADAG $1.44
- 52 Week High
- SRL $8.59
- ADAG $4.38
- Technical
- Relative Strength Index (RSI)
- SRL 30.77
- ADAG 44.51
- Support Level
- SRL $6.51
- ADAG $2.02
- Resistance Level
- SRL $7.58
- ADAG $2.25
- Average True Range (ATR)
- SRL 0.36
- ADAG 0.27
- MACD
- SRL -0.04
- ADAG -0.00
- Stochastic Oscillator
- SRL 21.82
- ADAG 27.08
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.